| Variables | No of patients (%) |
| Age at presentation: | |
| ≤ 1 month | 10 (16.1) |
| > 1 month and ≤1 year | 20 (32.3) |
| > 1 year and ≤ 5 years | 24 (38.7) |
| > 5 years | 8 (12.9) |
| Female gender | 36 (58.1) |
| ICU admission at presentation | 37 (59.7) |
| Preceding viral illness | 28 (46.7) |
| Family history of cardiomyopathy | 7 (11.3) |
| Medications within 1 week of presentation | |
| Digoxin | 38 (61.3) |
| Diuretics | 41 (66.1) |
| ACE I | 40 (64.5) |
| Steroids | 23 (37.1) |
| IVIG | 19 (30.6) |
| Inotrops (Dopamine, Dobutamine) | 33 (53.2) |
| Milrinone | 14 (22.6) |
| LVSF at presentation | |
| <15 | 24 (38.7) |
| ≥15 and <20 | 20 (32.3) |
| ≥20 | 18 (29) |
| LVEDD > 95%tile [n = 48]* | 28 (58) |